Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Attributions of survival and methods of coping of long-term ovarian cancer survivors: A qualitative study
    Journal Article

    Ketcher, D.; Lutgendorf, S. K.; Leighton, S.; Matzo, M.; Carter, J.; Peddireddy, A.; Karlan, B. Y.; Tew, W. P.; Sood, A. K.; Shinn, E. H.
    BMC Women's Health (2021)

    Fulltext@MSK | Save
  • The impact of race, education, and employment status on cost-coping strategies and patient reported benefit from interventions to mitigate financial toxicity
    Meeting Abstract

    Braxton, K.; Thom, B.; Brown, C. L.; Gany, F.; Chino, F.; Aviki, E. M.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Association of homologous recombination deficiency (HRD) with clinical outcomes in a phase III study of olaparib or cediranib and olaparib compared to platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (PSOC): Biomarker analyses from NRG-GY004
    Meeting Abstract

    Swisher, E.; Miller, A.; Kohn, E.; Brady, M.; Radke, M.; Pennil, C.; Khasnavis, N.; Buscema, J.; Tew, W.; Muller, C.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
    Meeting Abstract

    Hong, D. S.; SciMentum, S. L.; Tanyi, J.; MacMullen, L.; Jalbert, L.; Muzithras, V. P.; Zikaras, K.; Cao, L.; O'Cearbhaill, R. E.; Quintás-Cardama, A.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study
    Meeting Abstract

    Vergote, I. B.; Monk, B. J.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; Collins, D. C.; Mirza, M. R.; O'Malley, D.; Gennigens, C.; Pignata, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)
    Meeting Abstract

    Colombo, N.; Lorusso, D.; Casado Herráez, A.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Floquet, A.; Monk, B. J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111
    Meeting Abstract

    Makker, V.; Taylor, M. H.; Aghajanian, C.; Cohn, A. L.; Brose, M. S.; DiSimone, C.; Cao, A.; Suttner, L.; Loboda, A.; Cristescu, R.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel improves progression-free survival in patients with recurrent platinum-resistant ovarian cancer: A 3-arm, randomized, open-label, phase II study
    Meeting Abstract

    Colombo, N.; Nguyen, D. D.; Fleming, G. F.; Grisham, R. N.; Lorusso, D.; Van Gorp, T.; Oaknin, A.; Pashova, H. I.; Grauer, A.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of germline testing in patients with advanced cancers
    Journal Article

    Stadler, Z. K.; Maio, A.; Chakravarty, D.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; Tkachuk, K.; Fong, C. J.; Nguyen, B.; Erakky, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save